2014 2015
What we do Principles Specialization Mission Goals
PRweb
Canada Cancer and Aging Research Laboratory Launched
7 oct, 2014
Today announced the launch of its personalized medicine and research programs in Canada. The company plans to unfold its operations in two phases, working in the areas of a personalized medical approach for cancer treatment.
MarketWatch Wall Street Journal
Deep Knowledge Ventures Makes First Investment in Space
10 sept, 2014
Deep Knowledge Ventures, a Hong Kong-based venture capital fund that utilizes Artificial Intelligence software, announced today its first investment in aerospace. DKV has acquired a stake in Transplanetary.
Reuters
The Former Head of the Human Genome Project Joins InSilico Medicine
4 june, 2014
InSilico Medicine announced that Charles Cantor, Ph.D. will chair its Scientific Advisory Board. Dr. Cantor, one of the leaders of the Human Genome Project, has published more than 400 peer-reviewed articles.
PRweb
Leading Computer Scientist Joins InSilico Medicine's War on Aging and Cancer
28 may, 2014
Today Insilico Medicine, Inc., a Deep Knowledge Ventures' portfolio company based in Baltimore, that is using advances in genomics to discover new therapies to target aging and age-related diseases.
PRweb
Live Long & Prosper? A New Report Highlights Economic & Health Benefits of A Growing Regenerative Medicine Sector
22 may, 2014
Aging Analytics & The London Regenerative Medicine Network have co-published ‘Investing in Regenerative Medicine.
PRweb
Deep Knowledge Venture’s Appoints Intelligent Investment Analysis Software VITAL
13 may, 2014
DKV has appointed VITAL, a machine learning program capable of making investment recommendations to its board.
PRweb
Deep Knowledge Ventures Finances Life-Extension Start-up, Personalized Medicine Service
15 april, 2014
Deep Knowledge Ventures has announced seed investments into Pathway Pharmaceuticals in Hong Kong.
PRweb
Top Cancer Genomics Expert Joins New Lifespan Extension Start-up as COO
9 april, 2014
Today Insilico Medicine, Inc., a Baltimore-based company using advances in genomics to discover new therapies to target aging and age-related diseases.
PRweb
Pathway Pharmaceuticals to launch Personalised Cancer Treatment Service with OncoFINDER™ tool
3 april, 2014
Pathway Pharmaceuticals announced today that it is to launch a Personalized Cancer Treatment Service to enable medical professionals to predict the efficacy of therapies for individual cancer patients.
PR News Wire
THE APPOINTMENT OF DMITRY KAMINSKIY TO THE BOARD OF TRUSTEES ANNOUNCED
01 april, 2014
The Biogerontology Research Foundation announces the appointment of Dmitry Kaminskiy to the board of trustees.
PRweb
IN SILICO MEDICINE INC. LAUNCHES IN THE US TO USE ADVANCES IN TECHNOLOGY TO COMBAT AGING AND AGE-RELATED DISEASES
06 march, 2014
In Silico Medicine Inc, developing novel computer-assisted methods for drug discovery in aging research, has officially launched in the US.




Contact us
info@deepknowledgeventures.com

If you are here regarding our senior partner Dmitry Kaminskiy's award for longevity record, please proceed to specialized site. Thanks.